Arkolith/Insider Trading/RAPP/Form 4

Ceesay Abraham

Chief Executive Officer, DirectorRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Dec 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$324K
Net Open-Market Flow
-$324K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Sell(S)3K$30.04$84K569K
Dec 17, 2025Sell(S)515$31.04$16K31K
Dec 17, 2025Sell(S)2K$30.04$73K31K
Dec 17, 2025Sell(S)2K$28.84$70K571K
Dec 17, 2025Sell(S)600$31.04$19K568K
Dec 17, 2025Sell(S)2K$28.84$62K34K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-324826) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML